Biology Reference
In-Depth Information
DeTulleo, L., and Kirchhausen, T. (1998). The clathrin endocytic pathway in viral infection. EMBO
J. 17, 4585-4593.
Diederich, S., Dietzel, E., and Maisner, A. (2009). Nipah virus fusion protein: influence of cleavage
site mutations on the cleavability by cathepsin L, trypsin and furin. Virus Res. 145, 300-306.
Drummer, H. E., and Poumbourios, P. (2004). Hepatitis C virus glycoprotein E2 contains a mem-
brane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization
and viral entry. J. Biol. Chem. 279, 30066-30072.
Drummer, H. E., Boo, I., and Poumbourios, P. (2007). Mutagenesis of a conserved fusion peptide-like
motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. J. Virol.
88, 1144-1148.
Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., and
White, J. M. (2009). The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and
residues critical for host cell binding.
J. Virol. 83, 2883-2891.
Duisit, G., Conrath, H., Saleun, S., Folliot, S., Provost, N., Cosset, F. L., Sandrin, V., Moullier, P.,
and Rolling, F. (2002). Five recombinant simian immunodeficiency virus pseudotypes lead to
exclusive transduction of retinal pigmented epithelium in rat.
Mol. Ther. 6, 446-454.
Earp, L. J., Delos, S. E., Park, H. E., and White, J. M. (2005). The many mechanisms of viral
membrane fusion proteins.
Curr. Top. Microbiol. Immunol. 285, 25-66.
Empig, C. J., and Goldsmith, M. A. (2002). Association of the caveola vesicular system with cellular
entry by filoviruses.
J. Virol. 76, 5266-5270.
Endres, M. J., Jaffer, S., Haggarty, B., Turner, J. D., Doranz, B. J., O'Brien, P. J., Kolson, D. L., and
Hoxie, J. A. (1997). Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor
pseudotypes.
Science 278, 1462-1464.
English, E. P., Chumanov, R. S., Gellman, S. H., and Compton, T. (2006). Rational development of
beta-peptide inhibitors of human cytomegalovirus entry.
J. Biol. Chem. 281, 2661-2667.
Epand, R. M. (2003). Fusion peptides and the mechanism of viral fusion.
Biochim. Biophys. Acta
1614, 116-121.
Eren, R., Landstein, D., Terkieltaub, D., Nussbaum, O., Zauberman, A., Ben-Porath, J., Gopher, J.,
Buchnick, R., Kovjazin, R., Rosenthal-Galili, Z., Aviel, S., Ilan, E., et al. (2006). Preclinical
evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a
potential treatment to prevent HCV reinfection in liver transplant patients.
J. Virol.
80,
2654-2664.
Ericsson, T. A., Takeuchi, Y., Templin, C., Quinn, G., Farhadian, S. F., Wood, J. C., Oldmixon, B. A.,
Suling, K. M., Ishii, J. K., Kitagawa, Y., Miyazawa, T., Salomon, D. R., et al. (2003). Identification of
receptors for pig endogenous retrovirus. Proc. Natl. Acad. Sci. USA 100, 6759-6764.
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wolk, B., Hatziioannou, T.,
McKeating, J. A., Bieniasz, P. D., and Rice, C. M. (2007). Claudin-1 is a hepatitis C virus co-
receptor required for a late step in entry.
Nature 446, 801-805.
Fenouillet, E., Barbouche, R., and Jones, I. M. (2007). Cell entry by enveloped viruses: redox
considerations for HIV and SARS-coronavirus.
Antioxid. Redox Signal. 9, 1009-1034.
Fortin, J. F., Cantin, R., Lamontagne, G., and Tremblay, M. (1997). Host-derived ICAM-1 glyco-
proteins incorporated on human immunodeficiency virus type 1 are biologically active and
enhance viral infectivity.
J. Virol. 71, 3588-3596.
Frampton, A. R., Jr., Stolz, D. B., Uchida, H., Goins, W. F., Cohen, J. B., and Glorioso, J. C. (2007).
Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation
of the cellular kinase ROCK1.
J. Virol. 81, 10879-10889.
Frecha, C., Costa, C., Levy, C., Negre, D., Russell, S. J., Maisner, A., Salles, G., Peng, K. W.,
Cosset, F. L., and Verhoeyen, E. (2009). Efficient and stable transduction of resting B lymphocytes
and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral
vectors.
Blood 114, 3173-3180.
